The metabolic landscape of RAS-driven cancers from biology to therapy
Our understanding of how the RAS protein family, and in particular mutant KRAS promote metabolic dysregulation in cancer cells has advanced significantly over the last decade. In this Review, we discuss the metabolic reprogramming mediated by oncogenic RAS in cancer, and elucidating the underlying m...
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2022
|
Online Access: | https://hdl.handle.net/1721.1/136166.2 |